Skip to main content

Advertisement

SpringerLink
Log in

Comparison of daily oral iron replacement therapy with every other day treatment in female reproductive age patients with iron-deficiency anemia

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Iron-deficiency anemia (IDA) is accepted as the most common cause of anemia in the world. The main goals of iron replacement therapy are to normalize the hemoglobin level and to replace iron stores. Current guidelines for treating iron deficiency recommend daily divided doses of iron to increase absorption. Hepcidin is a key regulator of systemic iron balance and acts in harmony with intracellular iron metabolism. Daily dosing and divided doses may increase serum hepcidin and decrease iron absorption. In this study, it was aimed to compare the effectiveness of daily and every other day oral iron replacement therapy in women of reproductive age with iron-deficiency anemia. We included premenopausal female patients aged between 18 and 50 years with iron-deficiency anemia. Forty patients were given oral iron therapy at a daily dose of 2*80 mg (iron sulfate). Forty-three patients were given iron treatment at a dose of 2*80 mg (iron sulfate) every other day. After 2 months of oral iron therapy, there was a significant improvement in hemoglobin, mean corpuscular volume, serum iron, total iron-binding capacity, and transferrin saturation in both groups. The values of hemoglobin, serum iron, transferrin saturation, and ferritin significantly increased at the end of the treatment for both groups. Although the median hepcidin level on the 15th-day measurement in the every other day treatment group was higher than that in the daily treatment group, there was no significant difference. As a result, the patients’ compliance with the treatment can be increased by offering treatment every other day instead of daily, since it provides similar treatment effectiveness.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Vos T, Abajobir AA, Abate KH et al (2017) Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390:1211–1259

    Article  Google Scholar 

  2. World Health Organization (2021) Anaemia in women and children: WHO global anaemia estimates, 2021st edn. World Health Organization, Geneva

    Google Scholar 

  3. Cook JD (2005) Diagnosis and management of iron-deficiency anaemia. Best Pract Res Clin Haematol 18(2):319–332

    Article  CAS  Google Scholar 

  4. Taha A, Azhar S, Lone T et al (2014) Iron deficiency anaemia in reproductive age women attending obstetrics and gynecology outpatient of university health centre in Al-ahsa, Saudi Arabia. Afr J Tradit Complement Altern Med 11(2):339–342

    Article  CAS  Google Scholar 

  5. Stoffel NU, Cercamondi CI, Brittenham G, Zeder C, Geurts-Moespot AJ, Swinkels DW, Moretti D, Zimmermann MB (2017) Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials. Lancet Haematol 4(11):e524–e533

    Article  Google Scholar 

  6. Snook J, Bhala N, Beales Ian L P et al (2021) British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults. Gut 70(11):2030–2051

    Article  CAS  Google Scholar 

  7. Moretti D, Goede JS, Zeder C, Jiskra M, Chatzinakou V, Tjalsma H, Melse-Boonstra A, Brittenham G, Swinkels DW, Zimmermann MB (2015) Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood 126(17):1981–1989

    Article  CAS  Google Scholar 

  8. Oflas ND, Demircioğlu S, Doğan NY, Eker E, Kutlucan A, Doğan A, Aslan M, Demir C (2020) Comparison of the effects of oral iron treatment every day and every other day in female patients with iron deficiency anaemia. Intern Med J 50(7):854–858

    Article  Google Scholar 

  9. Nemeth E, Rivera S, Gabayan V et al (2004) IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113(9):1271–1276

    Article  CAS  Google Scholar 

  10. Lin L, Valore EV, Nemeth E, Goodnough JB, Gabayan V, Ganz T (2007) Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4. Blood 110(6):2182–2189

    Article  CAS  Google Scholar 

  11. Zimmermann MB, Troesch B, Biebinger R, Egli I, Zeder C, Hurrell RF (2009) Plasma hepcidin is a modest predictor of dietary iron bioavailability in humans, whereas oral iron loading, measured by stable-isotope appearance curves, increases plasma hepcidin. Am J Clin Nutr 90(5):1280–1287

    Article  CAS  Google Scholar 

  12. Kaundal R, Bhatia P, Arihantl J et al (2020) Randomized controlled trial of twice-daily versus alternate-day oral iron therapy in the treatment of iron-deficiency anemia. Ann Hematol 99(1):57–63

    Article  CAS  Google Scholar 

  13. De-Regil et al (2011) Intermittent iron supplementation for improving nutrition and development in children under 12 years of age. Cochrane Database Syst Rev 2011(12):9085

  14. Beaton George H, McCabe George P (2001) Efficacy of ıntermittent ıron supplementation in the control of ıron deficiency anaemia in developing countries. An analysıs of experience: Final report to The Micronutrient Initiative. 1999. Chapter 1. pp 1–3

  15. Fernández-Gaxiola AC, De-Regil LM, Nasser M (2011) Intermittent iron supplementation for reducing anaemia and its associated impairments in menstruating women. Cochrane Library (12):CD009218

  16. Smith GA, Fisher SA, Doree C, Di Angelantonio E, Roberts DJ (2014) Oral or parenteral iron supplementation to reduce deferral, iron deficiency and/or anaemia in blood donors. Cochrane Database Syst Rev (7):CD009532

  17. Peña-Rosas JP, De-Regil LM, Dowswell T, Viteri FE (2015) Intermittent oral iron supplementation during pregnancy. Cochrane Database Syst Rev 2015(10):CD009997

    PubMed Central  Google Scholar 

  18. Cook JD, Reddy MB (1995) Efficacy of weekly compared with daily iron supplementation. Am J Clin Nutr 62(1):117–120

    Article  CAS  Google Scholar 

  19. Mehta S, Sharma BS, Gulati S, Sharma N, Goyal LK, Mehta S (2020) A Prospective, randomized, ınterventional study of oral ıron supplementation comparing daily dose with alternate day regimen using hepcidin as a biomarker in ıron deficiency anemia. J Assoc Physicians India 68(5):39–41

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Adult Hematology, Gazi University Faculty of Medicine, Beşevler, 06500, Ankara, Turkey

    Lale Aydın Kaynar, Sanem Gökçen, Ferda Can, Zeynep Arzu Yeğin, Zübeyde Nur Özkurt & Münci Yağcı

Authors
  1. Lale Aydın Kaynar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sanem Gökçen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ferda Can
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zeynep Arzu Yeğin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zübeyde Nur Özkurt
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Münci Yağcı
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lale Aydın Kaynar.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kaynar, L.A., Gökçen, S., Can, F. et al. Comparison of daily oral iron replacement therapy with every other day treatment in female reproductive age patients with iron-deficiency anemia. Ann Hematol 101, 1459–1464 (2022). https://doi.org/10.1007/s00277-022-04835-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-022-04835-6

Keywords

Search

Navigation